California State Teachers Retirement System Acadia Pharmaceuticals Inc Transaction History

California State Teachers Retirement System

$83.3 Billion
Q4 2024

A detailed history of California State Teachers Retirement System transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, California State Teachers Retirement System holds 101,658 shares of ACAD stock, worth $2.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

101,658

Previous 102,234 0.56%

Holding current value

$2.01 Million

Previous $1.57 Million 18.56%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$14.29 - $18.76 $8,231 - $10,805	-576 Reduced 0.56%	101,658 $1.87 Million
Q3 2024 Nov 14, 2024	SELL	$15.14 - $19.14 $50,597 - $63,965	-3,342 Reduced 3.17%	102,234 $1.57 Million
Q2 2024 Aug 14, 2024	SELL	$14.62 - $18.42 $47,456 - $59,791	-3,246 Reduced 2.98%	105,576 $1.72 Million
Q1 2024 May 15, 2024	SELL	$17.79 - $30.86 $105,263 - $182,598	-5,917 Reduced 5.16%	108,822 $2.01 Million
Q4 2023 Feb 13, 2024	SELL	$20.78 - $31.77 $113,832 - $174,036	-5,478 Reduced 4.56%	114,739 $3.59 Million
Q3 2023 Nov 14, 2023	SELL	$20.84 - $33.47 $417,216 - $670,069	-20,020 Reduced 14.28%	120,217 $2.51 Million
Q2 2023 Aug 21, 2023	SELL	$17.8 - $25.65 $199,110 - $286,920	-11,186 Reduced 7.39%	140,237 $3.36 Million
Q1 2023 May 09, 2023	SELL	$16.32 - $20.92 $35,871 - $45,982	-2,198 Reduced 1.43%	151,423 $2.85 Million
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $27,945 - $36,663	1,968 Added 1.3%	153,621 $2.45 Million
Q3 2022 Nov 18, 2022	SELL	$14.11 - $18.27 $37,377 - $48,397	-2,649 Reduced 1.72%	151,653 $2.48 Million
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $6,765 - $14,154	520 Added 0.34%	154,302 $2.17 Million
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $272,973 - $358,490	-13,036 Reduced 7.81%	153,782 $3.73 Million
Q4 2021 Feb 15, 2022	BUY	$16.79 - $27.09 $59,419 - $95,871	3,539 Added 2.17%	166,818 $3.89 Million
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $263,352 - $413,386	-16,689 Reduced 9.27%	163,279 $2.71 Million
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $644,099 - $910,371	-33,201 Reduced 15.57%	179,968 $4.39 Million
Q1 2021 May 18, 2021	SELL	$25.02 - $54.99 $28,747 - $63,183	-1,149 Reduced 0.54%	213,169 $5.5 Million
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $180,658 - $249,989	4,402 Added 2.1%	214,318 $11.5 Million
Q3 2020 Nov 17, 2020	BUY	$36.42 - $57.0 $787,801 - $1.23 Million	21,631 Added 11.49%	209,916 $8.66 Million
Q2 2020 Aug 17, 2020	BUY	$39.26 - $52.73 $675,311 - $907,008	17,201 Added 10.05%	188,285 $9.13 Million
Q1 2020 May 13, 2020	SELL	$31.65 - $46.87 $26,807 - $39,698	-847 Reduced 0.49%	171,084 $7.23 Million
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $280,808 - $398,607	7,755 Added 4.72%	171,931 $7.36 Million
Q3 2019 Nov 15, 2019	BUY	$22.22 - $44.01 $43,573 - $86,303	1,961 Added 1.21%	164,176 $5.91 Million
Q2 2019 Aug 14, 2019	SELL	$23.32 - $28.12 $260,694 - $314,353	-11,179 Reduced 6.45%	162,215 $4.34 Million
Q1 2019 May 09, 2019	BUY	$16.17 - $27.38 $312,824 - $529,693	19,346 Added 12.56%	173,394 $4.66 Million
Q4 2018 Feb 13, 2019	BUY	$14.32 - $22.92 $49,747 - $79,624	3,474 Added 2.31%	154,048 $2.49 Million
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $703 - $1,177	-54 Reduced 0.04%	150,574 $3.13 Million
Q2 2018 Aug 14, 2018	BUY	$15.07 - $22.34 $693 - $1,027	46 Added 0.03%	150,628 $2.3 Million
Q1 2018 May 15, 2018	SELL	$22.47 - $32.33 $118,619 - $170,670	-5,279 Reduced 3.39%	150,582 $3.38 Million
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $9,581 - $13,972	357 Added 0.23%	155,861 $4.69 Million
Q3 2017 Nov 13, 2017	BUY	$29.49 - $38.37 $4.59 Million - $5.97 Million	155,504	155,504 $5.86 Million

Others Institutions Holding ACAD

# of Institutions

316

Shares Held

164M

Call Options Held

855K

Put Options Held

350K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.19B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account

California State Teachers Retirement System Acadia Pharmaceuticals Inc Transaction History